Vpl Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 4.99 M
as on 24-10-2024
- Company Age 25 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 22.46 Cr
as on 24-10-2024
About Vpl Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.99 M.
The company currently has active open charges totaling ₹20.00 Cr. The company has closed loans amounting to ₹22.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
Salim Shaikh and Akash Puranik serve as directors at the Company.
- CIN/LLPIN
U24100KA1999PTC025992
- Company No.
025992
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vpl Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Salim Shaikh  | Director | 30-Jun-2022 | Current |
| Akash Puranik | Director | 30-Jun-2022 | Current |
Financial Performance of Vpl Chemicals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vpl Chemicals?
Unlock access to Vpl Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Symbio Generrics India Private LimitedActive 13 years 7 monthsSalim Shaikh and Akash Puranik are mutual person
- Symbio Natural Products Private LimitedActive 7 years 1 month
Salim Shaikh and Akash Puranik are mutual person
Sequent Penems Private LimitedActive 14 years 7 monthsSalim Shaikh and Akash Puranik are mutual person
Copernicium Pharmaceuticals Private LimitedActive 11 years 20 daysSalim Shaikh and Akash Puranik are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Feb 2023 | ₹20.00 Cr | Open |
State Bank Of India Creation Date: 31 Mar 2018 | ₹5.47 Cr | Satisfied |
Others Creation Date: 24 Dec 2010 | ₹8.95 Cr | Satisfied |
How Many Employees Work at Vpl Chemicals?
Unlock and access historical data on people associated with Vpl Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vpl Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vpl Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
